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BACKGROUND Iatrogenic dissection (ICAD) of the left main coronary
artery (LM) and proximal LAD (p-LAD) during percutaneous coronary
intervention (PCI) is a much dreaded complication; however, little is
known regarding the long-term clinical outcome of these patients.
The aim of the present study was to evaluate the short- and long-term
clinical outcome of ICAD involving LM and p-LAD during PCI and to
compare it to those of non-LM dissections.
METHODS All consecutive ICAD during PCI were identiﬁed using
National Heart Lung and Blood Institute diagnostic criteria. The
cohort was divided into LM and p-LAD group and all other coronary
arteries as non-LM group. Demographic clinical, procedural and
follow-up data were collected. These patients were prospectively
followed for a 3-year period for the outcomes of major adverse car-
diovascular events (MACE) and cardiac death.
RESULTS A total of 1132 ICAD events were identiﬁed, of which 27%
occurred in the LM group. Lower incidence of LM ICAD was seen
during primary PCI (9 vs. 23, p¼0.04). Right coronary was the
commonest artery in the non-LM group. As a result of the dissec-
tion there was one death during the procedure in the non-LM
group. Forty-four patients (8 in the LM-P-LAD group) underwent
urgent coronary artery bypass grafting. In-hospital outcomes were
favorable with only 1 patient developing subacute stent thrombosis
in the non LM group and with 1 cardiac death in the non-LM group.
In the non-LM group, 4 patients underwent target vessel PCI. There
was no signiﬁcant difference in the rates of MACE or cardiac death
between the LM /p-LAD and non–LM group at 30 days, 1, 2 and
3 years.
CONCLUSIONS ICAD involving LM and p-LAD is a rare complication
of PCI procedure. Although considered a serious complication of PCI,
it does not necessarily portend a worse early or long-term clinical
outcome when compared to non-LM dissections.CATEGORIES CORONARY: Complications
KEYWORDS Dissection, Outcomes, Percutaneous coronary in-
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BACKGROUND Recently, the 1-year clinical and 9-month angiographic
results of The TRYTON (Prospective, Single Blind, Randomized Controlled
Study to Evaluate the Safety & Effectiveness of the Tryton Side Branch
Stent Used With DES in Treatment of de Novo Bifurcation Lesions in the
Main Branch & Side Branch in Native Coronaries) IDE trial were reported,
showing no difference in overall target vessel failure (TVF) using the
TRYTON (TrytonMedical Inc., Durham, North Carolina) stent compared to
the standard provisional approach. The lack of beneﬁt with the TRYTON
dedicated bifurcation stent strategy was predominantly driven by an
excess of small peri-proceduralmyocardial infarctions (MI) in the TRYTON
group, especially in smaller side branches (<2.5 mm diameter by visual
estimate). A subset analysis of the TRYTON trial examining the outcomes
in the larger side branches, indicated possible beneﬁt of TRYTON on both
angiographic and clinical outcomes. Therefore, the role of a dedicated
bifurcation stent strategy for the treatment of some complex bifurcation
lesions remains to be answered. Moreover, the long term clinical outcome
of the TRYTONdedicated bare-metal stent is unknown.Herewe report the
2-year clinical follow-up of the TRYTON IDE trial, including special atten-
tion to the large side branch cohort.
METHODS The TRYTON IDE trial randomly assigned patients with
true bifurcation lesions to a main vessel stent plus provisional stent-
ing or the bifurcation stent. The clinical primary endpoint was TVF
(cardiac death, target vessel MI, and target vessel revascularization).
The primary endpoint and its components will be reported and
compared between both strategies.
RESULTS The complete results will be available at the time of the
presentation.
CONCLUSIONS The conclusions will be available at the time of the
presentation.
CATEGORIES CORONARY: Complex and Higher Risk Procedures for
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BACKGROUND Robotic PCI can potentially address the occupational
hazards associated with interventional cardiology, addressing both
the orthopedic and radiation associated risks. The safety and feasi-
bility of robotically assisted percutaneous coronary intervention (PCI)
Clinical and Procedural Characteristics
Case # Age Sex Coronary Dominance Hemodynamic support Access Guide Wire Anticoagulation Antiplatelet
Ejection
Fraction Total Fluoroscopy Time Total Contrast Volume
1 43 M Right-dominant with patent
stents
No Femoral 7F-EBU 3.75 BMW Bivalirudin Aspirin þ Prasugrel 58% 45.9 min 450 mL
2 71 M Right-dominant with patent
vessel
No Femoral 6F-EBU 4.5 BMW Bivalirudin Aspirin þ Clopidogrel 50% 23.6 min 225 mL
3 80 M Right-dominant with patent
vessel
No Radial 7F-EBU 3.5 (sheath less) BMW Heparin Aspirin þ Ticagrelor 68% 18.9 min 165 mL
4 68 W Right-dominant; 100%
occlusion
Impella 2.5 LVAD Femoral 7F-EBU 3.75 BMW/Wiggle Heparin Aspirin þ Ticagrelor 62% 32.6 min 220 mL
5 70 M Right-dominant; patent RCA
stents
IABP Femoral 7F-EBU 3.5 BMW Bivalirudin ASA þ Clopidogrel 63% 13.1 min 135 mL
6 83 W Right-dominant; 90% prox
RCA
Impella CP Femoral 7F-EBU 3.5 BMW Bivalirudin ASA þ Ticagrelor 27% 26.7 min 250 mL
Angiographic Details of Left Main Lesion and Outcomes
Case # LM Pre-Intervention Stenosis LM Lesion Length LM Stent Implanted
LM Post-Intervention
Stenosis
Non-LM PCI (Total Vessels
Treated) Total # of Stents implanted Clinical Procedural Success Technical Success
Periprocedural
Complications
1 90% 25 mm Promus 3.5x20 0% Prox & mid LAD, diagonal
branch (3)
4 Yes Yes None
2 70% 8 mm Promus 4.0x12 0% None (1) 1 Yes Yes None
3 70% 15 mm Promus 4.0x16 0% Prox LAD (2) 2 Yes Yes Right forearm hematoma
4 80% 28 mm Promus 4.0x32 0% Mid LAD, LCX (2) 1 Yes Yes CK-MB 22.2
5 70% 34 mm Promus 2.75x38 mm 0% Prox LAD, LCX (2) 1 Yes Yes None
6 LM equivalent (90% ostial
LCX& 70% ostial LAD)
20 mm LAD, 12 mm LCX Xience 3.0x23 mm in LAD &
Xience 3.0x15 mm in LCX
0% LAD, LCX, and RCA (3) 3 Yes Yes None
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this study was to demonstrate the feasibility of robotic PCI for un-
protected left main stenosis.
METHODS The robotic CorPath 200 robotic system (Corindus Vascular
Robotics, Waltham, MA) consists of a robotic arm mounted on the
cardiac catheterization table that consists of a drive housing a single-
use sterile cassette, which is connected to the guiding catheter. While
sitting in the non-sterile, radiation-shielded cockpit, the operator
remotely controls delivery and removal of intracoronary devices
including the guidewire, angioplasty balloons, and stents. The data-
base for the ongoing PRECISION registry was queried at a single center
to identify all unprotected left main robotic PCI procedures performed
and outcomes are reported.
RESULTS During the study period 102 robotic PCI procedures were
performed our center of which 6 were identiﬁed as unprotected left
main stenosis (age 6914 years; 67% male). All 6 subjects underwent
successful PCI (ﬂuoroscopy time 26.811.4 min, with an average of 1.8
stents and 2.2 vessels treated/patient). Clinical and procedural success
was 100%. Three of the 6 subjects underwent robotic left main PCI
without hemodynamic support while 2 were supported with percu-
taneous left ventricular hemodynamic assistance using the Impella 2.5
device (Abiomed, Danvers, MA) and 1 with intra-aortic balloon pump.
CONCLUSIONS This is the ﬁrst report demonstrating the feasibility of
robotic PCI for unprotected left main stenosis. Left main disease was
treated robotically in the absence and presence of adjunctive hemo-
dynamic support. Though this report demonstrates the feasibility of
performing robotic PCI in a high-risk cohort of patients, further
studies are needed to examine the safety and effectiveness of this
approach in a larger sample of patients.
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BACKGROUND Rotational atherectomy (RA) is recommended by
current guidelines as a provisional (bailout) procedure for heavily
calciﬁed or severely ﬁbrotic coronary lesions that cannot be crossed by
a balloon or adequately dilated before stenting. There is little infor-
mation available on procedural, in-hospital, and long term outcome of
provisional RA as compared to a planned rotablation strategy for
complex calciﬁed coronary lesions.
METHODS We performed a retrospective cohort study of all consecutive
patients treated with RA for complex calciﬁed coronary lesions at our
institution between November 2002 and February 2014. Clinical follow-up
was obtained at 1 year by either clinic visit or telephone interview.
RESULTS During this time interval we identiﬁed a total of 512 patients
treated for 559 coronary lesions. 204 patients (39.8%) with 221 lesions
and 308 patients (60.2%) with 338 lesions were treatedwith provisional
and planned RA respectively. Overall, 380 patients (74.2%) weremales,
34.5% had diabetes mellitus and 7.2% had severe chronic renal failure.
A history of myocardial infarction was documented in 18.1% of the
provisional RA population and 27.9% of the elective RA group (p¼0.03).
Other baseline clinical characteristics were similar. Provisional RA
group had signiﬁcantly less lesions located in LAD (41.2% vs 57.1%.
p¼0.002) or involving a bifurcation (28.5% vs 41.1%, p¼0.002), but had
more chronic total occlusions (12.7% vs 2.4%, p<0.001) and more type
B2/C lesions (89.6% vs 80.8%, p¼0.005). DES were implanted in 84.2%
and 87.6% of lesions in the provisional and planned RA groups,
respectively. Coronary dissections occurred more frequently in the
provisional RA group (8.6% vs 4.4%, p¼0.04), and themean procedural
duration and median ﬂuoroscopy time were also longer in that group
(111 50min vs 76 35min, p<0.001 and 32min IQR 21-51 vs 18min IQR
14-28, p<0.001). Angiographic success (deﬁned as residual stenosis <
30%) was lower in the provisional RA group (93.7% vs 97.6%, p¼0.02).
In-hospital death occurred in 6 patients (2.9%) in the provisional RA
group and in 4 patients (1.3%) in the elective RA group (p¼0.21). In-
hospital major adverse cardiac events (MACE) deﬁned as death, MI and
target vessel revascularization (TVR) were signiﬁcantly higher in the
provisional RA group (10.3% vs 5.5%, p¼0.04). At one year follow-up
(available for 94.8% of patients), there was no statistically signiﬁcant
difference in the rates of MACE (18.3% for provisional RA vs. 18.6%
p¼0.52), death (6.5% vs 5.9% p¼0.51), spontaneous MI (1.3% vs 2.7%,
p¼0.29) and TVR (11.3% vs 11.4%, p¼0.52) between the two groups.
CONCLUSIONS In a comparison of provisional and planned RA in a
large cohort of patients treated for complex calciﬁed coronary lesions,
